Trajan Group Holdings Ltd
ASX:TRJ
Relative Value
There is not enough data to reliably calculate the relative value of TRJ.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
TRJ Competitors Multiples
Trajan Group Holdings Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
AU |
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
153.6m AUD | 0.9 | 81.3 | 20.4 | 20.4 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
222.3B USD | 5.2 | 37.1 | 22.9 | 33.6 | ||
US |
Danaher Corp
NYSE:DHR
|
182.8B USD | 4.2 | 22.7 | 16.5 | 20.3 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.3B USD | 2.8 | 31.1 | 16.9 | 26.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.6B USD | 6 | 32.9 | 26.3 | 31.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.2T KRW | 14.9 | 64.3 | 33.9 | 48.8 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.6B CHF | 5.6 | 57.5 | 19.7 | 28.9 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.8 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9.1 | 46.7 | 32.4 | 39.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
24.9B USD | 3 | 36.5 | 16.5 | 25.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.1B EUR | 7.1 | 75 | 32.3 | 53 |